维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Wijk JP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Impact of thiazolidinedione therapy on atherogenesis显示文摘	Wijk JP Rabelink TJ	2005	Curr Atheroscler Rep2005，7，5：	1
2	Impact of thiazolidinedione therapy on atherogenesis显示文摘	Van Wijk JP Rabellink TJ	2005	Curr Atheroscler Rep2005，7，5：	1
3	Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients显示文摘	de Koning EJ Cabezas MC	2006	J Am Coll Cardiol2006，47，6：	1
4	Impact of thiazolidinedione therapy on atherogenesis显示文摘	van Wijk JP Rabelink TJ	2005	Curr Atheroscler Rep2005，7，5：	1
5	Diurnal triglyceridaemia and insulin resistance in mildly obese subjects with normal fasting plasma lipids显示文摘	Halkes CJ Van Wijk JP Ribalta J	2004	Intern Med2004，255，1：	1
6	Fasting and daylong triglycerides in obesity with and without type 2 diabetes显示文摘	van Wijk JP Halkes CJ Erkelens DW	2003	Metabolism2003，52，8：	1
7	Challenges for the effective molecular imprinting of proteins 显示文摘	Verheyen E Schillemans JP Van Wijk M	2011	Biomaterials2011，32，：	1
8	Functional and structural markers of atheroselerosis in human immunodeficiency virus-infected patients显示文摘	van Wijk JP de Koning EJ Cabezas MC	2006	JAm Coil Cardiol2006，47，6：	1
9	Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes显示文摘	Van Wijk JP de Koning E J Castro Cabezas M	2005	Diabetes Care2005，28，：	1
10	Thiazolidinediones and blood lipids in type 2 diabetes显示文摘	Van Wijk JP de Koning E J Martens EP	2003	Arterioscler Thromb Vasc Biol2003，23，：	1
11	Impact of thiazolidinedione therapy on atherogenesis 显示文摘	Wijk JP Rabelink TJ	2005	Curr Atheroscler Rep2005，7，5：	1
12	Functional and structural markers of atherosclerosis in HIV-infected patients显示文摘	van Wijk JP de Koning EJ Cabezas MC	2006	J Am Coll Cardiol2006，47，6：	1
13	Impact of thiazolidinedione thera- py on atherogenesis显示文摘	Wijk JP Rabelink TJ	2005	Curr Atheroscler Rep2005，7，5：	1
14	Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2diabetes显示文摘	Van Wijk JP de Koning EJ Castro Cabezas M	2005	Diabetes Care2005，28，4：	1
15	Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes显示文摘	de Koning EJ Castro Cabezas M	2005	Diabetes Care2005，28，4：	1
16	hnpact of thiazolidinedione therapy on atherogenesis 显示文摘	van Wijk JP Rabelink TJ	2005	Curr Atheroscler Rep2005，7，5：	1
17	Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type2 diabetes显示文摘	Van Wijk JP De Koning EJ Castro C M	2005	Diabetes Care2005，28，4：	1
18	Thiazolidinediones and blood lipids in type 2 diabetes显示文摘	Van Wijk JP De Koning E J Martens EP	2003	Arteriosclerosis Thrombosis and Vascular Biology2003，23，10：	1
19	Rosiglitazone im- proves postprandial triglycefide and free fatty acid metabolism in type 2 diabetes显示文摘	van Wijk JP de Koning EJ Castro Cabelink M	2005	Diabetes Mert2005，28，4：	1
20	Effects of increasing doses of simvastatin on fasting lipoprotein subfractions,and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis显示文摘	van Wijk JP Buirma R van Tol A Halkes CJ De Jaegere PP Plokker HW	2005	Atherosclerosis2005，178，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示